U.S. flag An official website of the United States government
  1. Home
  2. Drugs
  3. News & Events for Human Drugs
  4. Identification of Medicinal Products: Path to Global Implementation - 06/11/2021 - 06/11/2021
  1. News & Events for Human Drugs

Webcast | Virtual

Event Title
Identification of Medicinal Products: Path to Global Implementation
June 11, 2021


Date:
June 11, 2021

Visit CDER Small Business and Industry Assistance Webpage

Download Slides

FDA will present updates on the Identification of Medicinal Products (IDMP) standards development and implementation with an emphasis on international collaboration, pilot projects on substance, dosage form and pharmaceutical identification (PhPID).

TOPICS

  • Overview of FDA’s Approach to IDMP and its global implementation
  • Collaboration with European Union (EU) European Medicines Agency on the implementation of the Global Substance Registration System (GSRS) and EU Substance Registration System (SRS)
  • Outcome of an international pilot evaluation to demonstrate the use of dose form characteristics as input in the generation of PhPID
  • GSRS a useful tool for substance registration in small businesses

INTENDED AUDIENCE

Pharmaceutical and regulatory authority professionals working in areas such as pharmacovigilance, product labeling, electronic submissions, and data standards.

FDA SPEAKERS

Ron Fitzmartin, PhD, MBA
Sr. Informatics Advisor
Office of the Director | Center for Biologics Evaluation and Research (CBER)

Ta-Jen Chen
Project Management Officer
Office of Strategic Programs | Center for Drug Evaluation and Research (CDER)

Tyler Peryea
Chemist
Office of Health Informatics (OHI) | Office of Chief Scientist (OCS)

Lawrence Callahan, PhD
Chemist
OHI | OCS

FDA RESOURCES

  1. IDMP Overview
  2. FDA Global Substance Registration System (GSRS)

TECHNICAL INFORMATION AND QUESTIONS

 
Back to Top